A postgenomic integratred view of prostaglandins in reproduction: Implications for other body systems

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL.1, 2008, Pages 65-89

  Fortier, Michel A ^a   Krishnaswamy, K ^b   Danyod, G ^b   Boucher Kovalik, S ^b   Chapdelaine J A , P ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b NONE

Author keywords

Aldose reductase; Female reproduction; Fertility; Ischemia; Menstrual disorders; Prostaglandis

Indexed keywords

ALDEHYDE REDUCTASE; CYCLOOXYGENASE 2; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; POLYUNSATURATED FATTY ACID; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; STEROID; THROMBOXANE A2; CYCLOOXYGENASE 1;

BIOSYNTHESIS; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CONFERENCE PAPER; DIET; ENDOMETRIUM; FEMALE GENITAL SYSTEM; GENOMICS; HUMAN; LIPID TRANSPORT; MENSTRUATION DISORDER; METABOLIC DISORDER; NONHUMAN; PHYSIOLOGY; REPRODUCTION; SIGNAL TRANSDUCTION; STEROID METABOLISM; ANIMAL; FEMALE; GENETICS; METABOLIC SYNDROME X; METABOLISM; REVIEW;

ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROST; DINOPROSTONE; FEMALE; HUMANS; MENSTRUATION DISTURBANCES; METABOLIC SYNDROME X; REPRODUCTION;

EID: 51349143108     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (135)

1. Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 2002; 68-69: 3-58.
2. Smith WL, Song I. The enzymology of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins Other Lipid Mediat 2002; 68-69: 115-128.
3. Sirois J. Richards JS. Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles. J Biol Chem 1992; 267(9): 6382-6388.
4. Parent JC, Villeneuve S, Fortier MA. Evaluation of the contribution of cyclooxygenase 1 and cyclooxygenase 2 to the production of PGE2 and PGF2 alpha in epithelial cells from bovine endometrium. Reproduction 2003; 126(4): 539-547.
5. Langenbach R, Morham SG, Tiano HF, Loftin CD, Ghanayem BI, Chulada PC, Mahler JF et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 1995; 83(3): 483-492.
6. Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF et al. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 1995; 83(3): 473-482.
7. Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 1997; 91(2): 197-208.
8. Reese J, Brown N, Paria BC, Morrow J, Dey SK. COX-2 compensation in the uterus of COX-1 deficient mice during the pre-implantation period. Mol Cell Endocrinol 1999; 150(1-2): 23-31.
9. Loftin CD, Trivedi DB, Tiano HF, Clark JA, Lee CA, Epstein JA, Morham SG et al. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. Proc Natl Acad Sci U S A, 2001; 98(3): 1059-1064.
10. Reese J, Paria BC, Brown N, Zhao X, Morrow JD, Dey SK. Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. Proc Natl Acad Sci U S A 2000; 97(17): 9759-9764.
11. Priddy AR, Killick SR, Elstein M, Morris J, Sullivan M, Patel L, Elder M. The effect of prostaglandin synthetase inhibitors on human preovulatory follicular fluid prostaglandin, thromboxane, and leukotriene concentrations. J Clin Endocrinol Metab 1990; 71(1): 235-242.
12. Klein T, Nüsing RM, Pfeilschifter J, Ullrich V. Selective inhibition of cyclooxygenase 2. Biochem Pharmacol 1994; 48(8) p. 1605-1610.
13. Gretzer B, Maricic N, Respondek M, Schuligoi R, Peskar BM. Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol 2001; 132(7): 1565-1573.
14. Hudson M, Richard H, Pilote L. Differences in outcomes of patients with congestive heart failure prescribed celecoxib, rofecoxib, or non-steroidal anti-inflammatory drugs: population based study. BMJ 2005; 330(7504): 1370.
15. Norman RJ, Wu R. The potential danger of COX-2 inhibitors. Fertil Steril 2004; 81(3):493-494.
16. Whitehouse MW. Prostanoids as friends, not foes: further evidence from the interference by cycloxygenase-inhibitory drugs when inducing tolerance to experimental arthritigens in rats. Inflammopharmacology 2005; 12(5): 481-492.
17. Zeilhofer HU. Brune K. Analgesic strategies beyond the inhibition of cyclooxygenases. Trends Pharmacol Sci 2006; 27(9): 467-474.
18. Bos CL, Richel DJ, Ritsema T, Peppelenbosch MP, Versteeg HH. Prostanoids and prostanoid receptors in signal transduction. Int J Biochem Cell Biol 2004; 36(7): 1187-1205.
19. Sales KJ, Jabbour HN. Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology. Prostaglandins Other Lipid Mediat 2003; 71(3-4): 97-117.
20. Hata AN, Breyer RM. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 2004; 103(2): 147-166.
21. Olson DM. The promise of prostaglandins: have they fulfilled their potential as therapeutic targets for the delay of preterm birth? J Soc Gynecol Investig 2005; 12(7): 466-478.
22. Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 1999; 20(5): 649-688.
23. Bhattacharya M, Peri K, Ribeiro-da-Silva A, Almazan G, Shichi H, Hou X et al. Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope. J Biol Chem 1999; 274(22): 15719-15724.
24. LindstromT, Bennett P. Transcriptional regulation of genes for enzymes of the prostaglandin biosynthetic pathway. Prostaglandins Leukot Essent Fatty Acids 2004;70(2): 115-135.
25. Jabbour HN, Sales KJ. Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol Metab 2004, 15(8): 398-404.
26. Sales KJ, Jabbour HN. Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction 2003; 126(5): 559-567.
27. Smith SK, Kelly RW. The release of PGF2 alpha and PGE2 from separated cells of human endometrium and decidua. Prostaglandins Leukot Essent Fatty Acids 1988; 33(2): 91-96.
28. Madore E, Harvey N, Parent J, Chapdelaine P, Arosh JA, Fortier MA. An aldose reductase with 20 alpha-hydroxysteroid dehydrogenase activity is most likely the enzyme responsible for the production of prostaglandin f2 alpha in the bovine endometrium. J Biol Chem 2003; 278(13): 11205-11212.
29. Bonventre JV, Huang Z, Taheri MR, O'Leary E, Li E, Moskowitz MA et al. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 1997; 390(6660): 622-625.
30. Sugimoto Y, Yamasaki A, Segi E, Tsuboi K, Aze Y, Nishimura T et al. Failure of parturition in mice lacking the prostaglandin F receptor. Science 1997; 277(5326): 681-683.
31. Kennedy CR, Zhang Y, Brandon S, Guan Y, Coffee K, Funk CD et al. Salt-sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor. Nat Med 1999; 5(2): 217-220.
32. Tilley SL, Audoly LP, Hicks EH, Kim HS, Flannery PJ, Coffman TM et al. Reproductive failure and reduced blood pressure in mice lacking the EP2 prostaglandin E2 receptor. J Clin Invest 1999; 103(11): 1539-1545.
33. Vincent DL, Inskeep EK. Role of progesterone in regulating uteroovarian venous concentrations of PGF2 alpha and PGE2 during the estrous cycle and early pregnancy in ewes. Prostaglandins 1986; 31(4): 715-733.
34. Nagle CA, Mendizábal AF, Lahoz MM, Porta MM, Torres MI. Transfer pathways between the ovaries and the uterus in the cebus monkeys (Cebus apella). Gen Comp Endocrinol 2005; 144(3): 248-256.
35. Hagstrom HG, Hahlin M, Bennegard-Edén B, Bourne T, Hamberger L. Regulation of corpus luteum function in early human pregnancy. Fertil Steril 1996; 65(1): p. 81-86.
36. Arosh JA, Parent J, Chapdelaine P, Sirois J, Fortier MA. Expression of cyclooxygenases 1 and 2 and prostaglandin E synthase in bovine endometrial tissue during the estrous cycle. Biol Reprod 2002; 67(1): 161-169.
37. Ni H, Sun T, Ding NZ, Ma XH, Yang ZM. Differential expression of microsomal prostaglandin e synthase at implantation sites and in decidual cells of mouse uterus. Biol Reprod 2002; 67(1): 351-358.
38. Ni H, Sun T, Ma XH, Yang ZM. Expression and regulation of cytosolic prostaglandin E synthase in mouse uterus during the peri-implantation period. Biol Reprod 2003; 68(3): 744-750.
39. Fortier MA, Boulet AP, Dugré FJ, Lambert RD. Local alteration in adenylate cyclase activity and stimulation response at implantation site in rabbit endometrium during early pregnancy. Biol Reprod 1990; 42(1): 106-113.
40. Psychoyos A, Nikas G, GravanisA. The role of prostaglandins in blastocyst implantation. Hum Reprod 1995; 10 (Suppl 2): 30-42.
41. Linnemeyer PA, Pollack SB. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells. J Immunol 1993; 150(9): 3747-3754.
42. Bergeron D, Ouellette MJ, Lambert RD. PGE2, but not TGF beta 2, in rabbit blastocoelic fluid regulates the cytotoxic activities of NK and LAK cells. J Reprod Immunol 1997; 33(3): 203-219.
43. Jabbour HN, Kelly RW, Fraser HM, Critchley HO. Endocrine regulation of menstruation. Endocr Rev, 2006. 27(1): p. 17-46.
44. Fraser IS. Prostaglandins, prostaglandin inhibitors and their roles in gynaecological disorders. Baillieres Clin Obstet Gynaecol 1992; 6(4): 829-857.
45. Narumiya S. FitzGerald GA. Genetic and pharmacological analysis of prostanoid receptor function. J Clin Invest 2001; 108(1): 25-30.
46. Asselin E, Goff AK, Bergeron H, Fortier MA. Influence of sex steroids on the production of prostaglandins F2 alpha and E2 and response to oxytocin in cultured epithelial and stromal cells of the bovine endometrium. Biol Reprod 1996; 54(2): 371-379.
47. Kim JJ, Fortier MA. Cell type specificity and protein kinase C dependency on the stimulation of prostaglandin E2 and prostaglandin F2 alpha production by oxytocin and platelet-activating factor in bovine endometrial cells. J Reprod Fertil 1995; 103(2): 239-247.
48. Chapdelaine P, Kang J, Boucher-Kovalik S, Caron N, Tremblay JP, Fortier MA. Decidualization and maintenance of a functional prostaglandin system in human endometrial cell lines following transformation with SV40 large T antigen. Mol Hum Reprod 2006; 12(5): 309-319.
49. Watanabe K, Yoshida R, Shimizu T, Hayaishi O. Enzymatic formation of prostaglandin F2 alpha from prostaglandin H2 and D2. Purification and properties of prostaglandin F synthetase from bovine lung. J Biol Chem 1985; 260(11): 7035-7041.
50. Kuchinke W, Barski O, Watanabe K, Hayaishi O. A lung type prostaglandin F synthase is expressed in bovine liver: cDNA sequence and expression in E. coli. Biochem Biophys Res Commun 1992; 183(3): 1238-1246.
51. Chen LY, Watanabe K, Hayaishi O. Purification and characterization of prostaglandin F synthase from bovine liver. Arch Biochem Biophys 1992; 296(1): 17-26.
52. Suzuki T, Fujii Y, Miyano M, Chen LY, Takahashi T, Watanabe K. cDNA cloning, expression, and mutagenesis study of liver-type prostaglandin F synthase. J Biol Chem 1999; 274(1): 241-248.
53. Suzuki-Yamamoto T, Nishizawa M, Fukui M, Okuda-Ashitaka E, Nakajima T, Ito S et al. cDNA cloning, expression and characterization of human prostaglandin F synthase. FEBS Lett 1999; 462(3): 335-340.
54. Wu WX, Ma XH, Yoshizato T, Shinozuka N, Nathanielsz PW. Increase in prostaglandin H synthase 2, but not prostaglandin F2alpha synthase mRNA in intrauterine tissues during betamethasone-induced premature labor and spontaneous term labor in sheep. J Soc Gynecol Investig 2001; 8(2): 69-76.
55. Kubata BK, Duszenko M, Kabututu Z, Rawer M, Szallies A, Fujimori K et al. Identification of a novel prostaglandin f(2alpha) synthase in Trypanosoma brucei. J Exp Med 2000; 192(9): 1327-1338.
56. Waclawik A, Rivero-Muller A, Blitek A, Kaczmarek MM, Brokken LJ, Watanabe K et al. Molecular cloning and spatiotemporal expression of prostaglandin F synthase and microsomal prostaglandin E synthase-1 in porcine endometrium. Endocrinology 2006; 147(1): 210-221.
57. Jin Y, Penning TM. Aldo-keto reductases and bioactivation/detoxication. Annu Rev Pharmacol Toxicol 2007; 47: 263-292.
58. Srivastava SK, Ramana KV, Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 2005; 26(3): 380-392.
59. Kang J, Chapdelaine P, Laberge PY, Fortier MA. Functional characterization of prostaglandin transporter and terminal prostaglandin synthases during decidualization of human endometrial stromal cells. Hum Reprod 2006; 21(3): 592-599.
60. Jakobsson PJ, Mancini JA, Riendeau D, Ford-Hutchinson. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A 1999; 96(13): 7220-7225.
61. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, Kojima F et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000; 275(42): 32783-32792.
62. Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 2000; 275(42): 32775-32782.
63. Tanikawa N, Ohmiya Y, Ohkubo H, Hashimoto K, Kangawa K, Kojima M et al. Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun 2002; 291(4): 884-889.
64. Murakami M, Nakashima K, Kamei D, Masuda S, Ishikawa Y, Ishii T et al. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J Biol Chem 2003; 278(39): 37937-37947.
65. Parent J, Fortier MA. Expression and contribution of three different isoforms of prostaglandin E synthase in the bovine endometrium. Biol Reprod 2005; 73(1): 36-44.
66. Parent J, Chapdelaine P, Fortier MA. Molecular cloning and tissue distribution of microsomal-1 and cytosolic prostaglandin E synthases in macaque. Prostaglandins Other Lipid Mediat 2005; 78(1-4): 27-37.
67. Helliwell RJ, Adams LF, Mitchell MD. Prostaglandin synthases: recent developments and a novel hypothesis. Prostaglandins Leukot Essent Fatty Acids 2004; 70(2): 101-113.
68. Nakashima K, Ueno N, Kamei D, Tanioka T, Nakatani Y, Murakami M et al. Coupling between cyclooxygenases and prostaglandin F(2alpha) synthase. Detection of an inducible, glutathione-activated, membrane-bound prostaglandin F(2alpha)-synthetic activity. Biochim Biophys Acta 2003; 1633(2): 96-105.
69. Asselin E, Drolet P, Fortier MA. Cellular mechanisms involved during oxytocin-induced prostaglandin F2alpha production in endometrial epithelial cells in vitro: role of cyclooxygenase-2. Endocrinology 1997; 138(11): 4798-4805.
70. Asselin E, Lacroix D, Fortier MA. IFN-tau increases PGE2 production and COX-2 gene expression in the bovine endometrium in vitro. Mol Cell Endocrinol 1997; 132(1-2): 117-126.
71. Kang J, Akoum A, Chapdelaine P, Laberge P, Poubelle PE, Fortier MA. Independent regulation of prostaglandins and monocyte chemoattractant protein-1 by interleukin-1beta and hCG in human endometrial cells. Hum Reprod 2004; 19(11): 2465-2473.
72. Nishinaka T, Yabe-Nishimura C. Transcription factor Nrf2 regulates promoter activity of mouse aldose reductase (AKR1B3) gene. J Pharmacol Sci 2005; 97(1): 43-51.
73. Lopez-Rodriguez C, Antos CL, Shelton JM, Richardson JA, Lin F, Novobrantseva TI et al. Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression. Proc Natl Acad Sci U S A 2004; 101(8): 2392-2397.
74. Lee JM, Chan K, Kan YW, Johnson JA. Targeted disruption of Nrf2 causes regenerative immune-mediated hemolytic anemia. Proc Natl Acad Sci U S A 2004; 101(26): 9751-9756.
75. Iwata T, Sato S, Jimenez J, McGowan M, Moroni M, Dey A et al. Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-alpha. J Biol Chem 1999; 274(12): 7993-8001.
76. Yaekashiwa M, Wang LH. Nrf2 regulates thromboxane synthase gene expression in human lung cells. DNA Cell Biol 2003; 22(8): 479-487.
77. Lindstrom TM, Bennett PR. The role of nuclear factor kappa B in human labour. Reproduction 2005; 130(5): 569-581.
78. Naraba H, Yokoyama C, Tago N, Murakami M, Kudo I, Fueki M et al. Transcriptional regulation of the membrane-associated prostaglandin E2 synthase gene. Essential role of the transcription factor Egr-1. J Biol Chem 2002; 277(32): 28601-28608.
79. Tan L, Peng H, Osaki M, Choy BK, Auron PE, Sandell LJ et al. Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1beta. J Biol Chem 2003; 278(20): 17688-17700.
80. Cui MZ, Parry GC, Oeth P, Larson H, Smith M, Huang RP et al. Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1. J Biol Chem 1996; 271(5): 2731-2739.
81. Lee SL, Sadovsky Y, Swirnoff AH, Polish JA, Goda P, Gavrilina G et al. Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 1996; 273(5279): 1219-1221.
82. Lappas M, Permezel M, Rice GE. Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J Clin Endocrinol Metab 2004; 89(11): 5627-5633.
83. Li N, Karin M. Is NF-kappaB the sensor of oxidative stress? FASEB J 1999; 13(10): 1137-1143.
84. Paron I, D'Elia A, D'Ambrosio C, Scaloni A, D'Aurizio F, Prescott A et al. A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells. Biochem J 2004; 378(Pt 3): 929-937.
85. Schuster VL. Prostaglandin transport. Prostaglandins Other Lipid Mediat 2002; 68-69: 633-647.
86. Reid G, Wielinga P, Zelcer N, van der Heijden I, Kuil A, de Haas M et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci U S A 2003; 100(16): 9244-9249.
87. Kanai N, Lu R, Satriano JA, Bao Y, Wolkoff AW, Schuster VL. Identification and characterization of a prostaglandin transporter. Science 1995; 268(5212): 866-869.
88. Lu R, Kanai N, Bao Y, Schuster VL. Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT). J Clin Invest 1996; 98(5): 1142-1149.
89. Banu SK, Arosh JA, Chapdelaine P, Fortier MA. Molecular cloning and spatio-temporal expression of the prostaglandin transporter: a basis for the action of prostaglandins in the bovine reproductive system. Proc Natl Acad Sci U S A 2003; 100(20): 11747-11752.
90. Arosh JA, Banu SK, Chapdelaine P, Madore E, Sirois J, Fortier MA. Prostaglandin biosynthesis, transport, and signaling in corpus luteum: a basis for autoregulation of luteal function. Endocrinology 2004; 145(5): 2551-2560.
91. Arosh JA, Banu SK, Kimmins S, Chapdelaine P, Maclaren LA, Fortier MA. Effect of interferon-tau on prostaglandin biosynthesis, transport, and signaling at the time of maternal recognition of pregnancy in cattle: evidence of polycrine actions of prostaglandin E2. Endocrinology 2004; 145(11): 5280-5893.
92. Banu SK Arosh JA, Chapdelaine P, Fortier MA. Expression of prostaglandin transporter in the bovine uterus and fetal membranes during pregnancy. Biol Reprod 2005; 73(2): 230-236.
93. Kang J, Chapdelaine P, Parent J, Madore E, Laberge PY, Fortier MA. Expression of human prostaglandin transporter in the human endometrium across the menstrual cycle. J Clin Endocrinol Metab 2005; 90(4): 2308-2313.
94. Nomura T, Chang HY, Lu R, Hankin J, Murphy RC, Schuster VL. Prostaglandin signaling in the renal collecting duct: release, reuptake, and oxidation in the same cell. J Biol Chem 2005; 280(31): 28424-28429.
95. Kankofer M. The enzymes responsible for the metabolism of prostaglandins in bovine placenta. Prostaglandins Leukot Essent Fatty Acids 1999; 61(6): 359-362.
96. Patel FA, Challis JR. Prostaglandins and uterine activity. Front Horm Res 2001; 27: 31-56.
97. Winchester SK, Imamura T, Gross GA, Muglia LM, Vogt SK, Wright J et al. Coordinate regulation of prostaglandin metabolism for induction of parturition in mice. Endocrinology 2002; 143(7): 2593-2598.
98. Backlund MG, Mann JR, Holla VR, Buchanan FG, Tai HH, Musiek ES et al. 15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer. J Biol Chem 2005; 280(5): 3217-3223.
99. Mitchell MD, Goodwin V, Mesnage S, Keelan JA. Cytokine-induced coordinate expression of enzymes of prostaglandin biosynthesis and metabolism: 15-hydroxyprostaglandin dehydrogenase. Prostaglandins Leukot Essent Fatty Acids 2000; 62(1): 1-5.
100. Brzozowski T, Konturek PC, Sliwowski Z et al. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in stomach of humans and experimental animals. J Physiol Pharmacol 2006; 57 (suppl. 3):67-79.
101. Alvin PE, Litt IF. Current status of the etiology and management of dysmenorrhea in adolescence. Pediatrics 1982; 70(4): 516-525.
102. Sampalis F, Bunea R, Pelland MF, Kowalski O, Duguet N, Dupuis S. Evaluation of the effects of Neptune Krill Oil on the management of premenstrual syndrome and dysmenorrhea. Altern Med Rev 2003;8(2):171-179.
103. Lands WE. Biochemistry and physiology of n-3 fatty acids. FASEB J 1992; 6(8): 2530-536.
104. Agarwal A, Saleh RA, Bedaiwy MA. Role of reactive oxygen species in the pathophysiology of human reproduction. Fertil Steril 2003; 79(4): 829-843.
105. Sugino N, Karube-Harada A, Kashida S, Takiguchi S, Kato H. Reactive oxygen species stimulate prostaglandin F2 alpha production in human endometrial stromal cells in vitro. Hum Reprod 2001; 16(9): 1797-1801.
106. Poyser NL. The control of prostaglandin production by the endometrium in relation to luteolysis and menstruation. Prostaglandins Leukot Essent Fatty Acids 1995; 53(3): 147-195.
107. Nishihara I, Minami T, Uda R, Ito S, Hyodo M, Hayaishi. Effect of NMDA receptor antagonists on prostaglandin E2-induced hyperalgesia in conscious mice. Brain Res 1995; 677(1): 138-44.
108. Milne SA, Perchick GB, Boddy SC, Jabbour HN. Expression, localization, and signaling of PGE(2) and EP2/EP4 receptors in human nonpregnant endometrium across the menstrual cycle. J Clin Endocrinol Metab 2001; 86(9): 4453-4459.
109. Barisani D, Meneveri R, Ginelli E, Cassani C, Conte D. Iron overload and gene expression in HepG2 cells: analysis by differential display. FEBS Lett 2000; 469(2-3): 208-212.
110. O'Connor T, Ireland LS, Harrison DJ, Hayes JD. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem J 1999; 343 (Pt 2): 487-504.
111. Yang J, Moravec CS, Sussman MA, DiPaola NR, Fu D, Hawthorn L et al. Decreased SLIM1 expression and increased gelsolin expression in failing human hearts measured by high-density oligonucleotide arrays. Circulation 2000; 102(25): 3046-3052.
112. Konturek SJ, Pawlik WW. Polish historical traces in cardiovascular pathophysiology and cardiac surgery. J Physiol Pharmacol 2006; 57 (suppl. 1): 3-4.
113. Rittner HL, Hafner V, Klimiuk PA, Szweda LI, Goronzy JJ, Weyand CM. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J Clin Invest 1999; 103(7): 1007-1013.
114. Ruef J, Liu SQ, Bode C, Tocchi M, Srivastava S, Runge MS et al. Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury. Arterioscler Thromb Vasc Biol 2000; 20(7): 1745-1752.
115. Kassab E, McFarlane SI, Sower JR. Vascular complications in diabetes and their prevention. Vasc Med 2001; 6(4): 249-525.
116. Srivastava S, Chandra A, Bhatnagar A, Srivastava SK, Ansari NH. Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase. Biochem Biophys Res Commun 1995; 217(3): 741-746.
117. Vander Jagt DL, Kolb NS, Vander Jagt TJ, Chino J, Martinez FJ, Hunsaker LA et al. Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. Biochim Biophys Acta 1995; 1249(2): 117-126.
118. Srivastava S, Chandra A, Wang LF, Seifert WE Jr, DaGue BB, Ansari NH et al. Metabolism of the lipid peroxidation product, 4-hydroxy-trans-2-nonenal, in isolated perfused rat heart. J Biol Chem 1998; 273(18): 10893-10900.
119. Srivastava SK, Chandra A, Srivastava S, Petrash JM, Bhatnagar A. Regulation of aldose reductase by aldehydes and nitric oxide. Adv Exp Med Biol 1999; 463: 501-507.
120. Dixit BL, Balendiran GK, Watowich SJ, Srivastava S, Ramana KV, Petrash JM et al. Kinetic and structural characterization of the glutathione-binding site of aldose reductase. J Biol Chem 2000; 275(28): 21587-21595.
121. Ramana KV, Dixit BL, Srivastava S, Balendiran GK, Srivastava SK, Bhatnagar A. Selective recognition of glutathiolated aldehydes by aldose reductase. Biochemistry 2000; 39(40): 12172-12180.
122. Kasajima H, Yamagishi S, Sugai S, Yagihashi N, Yagihashi S. Enhanced in situ expression of aldose reductase in peripheral nerve and renal glomeruli in diabetic patients. Virchows Arch 2001; 439(1): 46-54.
123. Helmersson J, Vessby B, Larsson A, Basu S. Cyclooxygenase- mediatedprostaglandin F2alpha is decreased in an elderly population treated with low-dose aspirin. Prostaglandins Leukot Essent Fatty Acids 2005; 72(4): 227-233.
124. Iwata K, Nishinaka T, Matsuno K, Kakehi T, Katsuyama M, Ibi M et al. The activity of aldose reductase is elevated in diabetic mouse heart. J Pharmacol Sci 2007; 103(4): 408-146.
125. Kaiserova K, Srivastava S, Hoetker JD, Awe SO, Tang XL, Cai J et al. Redox activation of aldose reductase in the ischemic heart. J Biol Chem 2006; 281(22): 15110-15120.
126. Kaneko M, Bucciarelli L, Hwang YC, Lee L, Yan SF, Schmidt AM et al. Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury. Ann N Y Acad Sci 2005; 1043: 702-709.
127. Lo AC, Cheung AK, Hung VK, Yeung CM, He QY, Chiu JF et al. Deletion of aldose reductase leads to protection against cerebral ischemic injury. J Cereb Blood Flow Metab 2007; 27(8): 1496-1509.
128. Ho EC, Lam KS, Chen YS, Yip JC, Arvindakshan M, Yamagishi S et al. Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage. Diabetes 2006; 55(7): 1946-1953.
129. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996; 271(52): p. 33157-33160.
130. Miralpeix M, Camacho M, López-Belmonte J, Canalías F, Beleta J, Palacios JM et al. Selective induction of cyclo-oxygenase-2 activity in the permanent human endothelial cell line HUV-EC-C: biochemical and pharmacological characterization. Br J Pharmacol 1997; 121(2): 171-180.
131. Gierse JK, Hauser SD, Creely DP, Koboldt C, Rangwala SH, Isakson PC, Seibert K. Expression and selective inhibition of the constitutive and inducible forms of human cyclooxygenase. Biochem J 1995; 305 (Pt 2): 479-484.
132. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci U S A 1999; 96(13): 7563-7568.
133. Ehrich EW, Dallob A, De Lepeleire I, Van Hecken A, Riendeau D, Yuan W et al. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther 1999; 65(3): 336-347.
134. Gierse JK, Zhang Y, Hood WF, Walker MC, Trigg JS, Maziasz TJ et al. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity. J Pharmacol Exp Ther 2005; 312(3): 1206-1212.
135. Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci U S A 1998; 95(22): 13313-13318.